| Literature DB >> 25175787 |
Chun-Hua Wang1, Pai-Chien Chou, Wen-Ching Joa, Li-Fei Chen, Te-Fang Sheng, Shu-Chuan Ho, Horng-Chyuan Lin, Chien-Da Huang, Fu-Tsai Chung, Kian Fan Chung, Han-Pin Kuo.
Abstract
BACKGROUND: Moderate-intensity exercise training improves skeletal muscle aerobic capacity and increased oxidative enzyme activity, as well as exercise tolerance in COPD patients.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25175787 PMCID: PMC4236722 DOI: 10.1186/1471-2466-14-142
Source DB: PubMed Journal: BMC Pulm Med ISSN: 1471-2466 Impact factor: 3.317
Characteristics of patients with chronic obstructive pulmonary disease (COPD)
| Age, yrs | 71.9 ± 2.7 | 71.4 ± 1.9 | 0.890 |
| Gender, male | 14 | 12 | 1.000 |
| Body mass index, kg/m2 | 24.5 ± 0.7 | 22.4 ± 1.0 | 0.094 |
| SGRQ score | 38.1 ± 4.2 | 32.0 ± 4.0 | 0.307 |
| Walking distance (ISWT), M | 251.4 ± 21.0 | 261.5 ± 29.9 | 0.782 |
| FVC, L | 1.9 ± 0.1 | 2.2 ± 0.2 | 0.158 |
| FVC, % pred. | 58.2 ± 4.2 | 67.5 ± 4.9 | 0.163 |
| FEV1, L | 1.2 ± 0.2 | 1.5 ± 0.2 | 0.285 |
| FEV1, % pred. | 54.2 ± 6.7 | 63.5 ± 7.0 | 0.349 |
| FEV1/FVC, % | 63.4 ± 2.9 | 64.9 ± 4.6 | 0.784 |
| IC before ISWT, L | 1.2 ± 0.1 | 1.2 ± 0.1 | 0.731 |
| IC after ISWT, L | 1.2 ± 0.1 | 1.2 ± 0.1 | 0.615 |
| Delta IC* | −0.04 ± 0.1 | −0.05 ± 0.1 | 0.815 |
Definition of abbreviations: ISWT = incremental shuttle walk test; SGRQ = San George Respiratory questionnaire; FEV1 = forced expiratory volume in 1 s; FVC = forced vital capacity; IC = inspiratory capacity* Change in inspiratory capacity on exercise
Data expressed as mean ± SE.
Figure 1Incremental shuttle walking test (ISWT) was performed in the mobile phone group (N = 12) and the control group (N = 14) at baseline and after 1, 2, 3, 6 months. The sample size was 12 in the mobile phone group and 14 in the control group at each time point. Results are shown as mean ± SE. *P < 0.05, **P < 0.01 compared to the baseline. #P < 0.05 compared to the control group.
Evaluation of limb muscle strength
|
| ||||||
|---|---|---|---|---|---|---|
| | ||||||
| | | | | | | |
| | 13.3 ± 0.7 | 12.2 ± 0.7 | 12.6 ± 0.5 | 13.0 ± 0.6 | 13.1 ± 0.5 | 0.354 |
| | 13.6 ± 0.8 | 12.4 ± 2.9 | 13.0 ± 0.5 | 13.3 ± 0.7 | 13.2 ± 0.6 | 0.953 |
| | | | | | | |
| | 12.2 ± 0.9 | 10.5 ± 0.7 | 12.6 ± 0.8 | 12.8 ± 0.6 | 12.8 ± 0.6 | 0.098 |
| | 12.0 ± 0.8 | 10.5 ± 0.7 | 12.2 ± 0.7 | 12.7 ± 0.6 | 12.7 ± 0.6 | 0.114 |
| | ||||||
| | | | | | | |
| | 11.8 ± 0.5 | 12.4 ± 0.6 | 12.9 ± 0.5* | 13.3 ± 0.5** | 13.5 ± 0.5** | 0.015 |
| | 11.5 ± 0.6 | 12.6 ± 0.5 | 13.5 ± 0.4* | 14.3 ± 0.5*** | 14.7 ± 0.4*** | <0.001 |
| | | | | | | |
| | 10.9 ± 0.8 | 11.8 ± 0.8 | 12.3 ± 0.7 | 13.7 ± 0.9 | 14.7 ± 0.7*# | 0.016 |
| | 10.8 ± 0.8 | 11.5 ± 0.7 | 12.0 ± 0.8 | 13.9 ± 0.9* | 15.1 ± 0.7**# | 0.002 |
Definition of abbreviations: M, month; kg, kilogram. Data present as mean ± SE.
aP value was determined by analysis of variance with repeated measures.
*P < 0.05, **P < 0.01, ***P < 0.001 compared to the baseline of corresponding group. #p < 0.05 compared to the control group at the same time.
Figure 2Plasma levels of C-reactive protein (CRP) were measured in the mobile phone group and control group at baseline, 1, 2, 3 and 6 months. The sample size was 12 in the mobile phone group and 14 in the control group at each time point. *P < 0.05, **P < 0.01, ***P < 0.001compared with the baseline level of corresponding group. #P < 0.05 compared to the control group.
Figure 3Plasma levels of interleukin (IL)-8 were measured at baseline, 1, 2, 3 and 6 months in the mobile phone group (n = 12) and the control group (n = 14). *P < 0.05, **P < 0.01 compared to the baseline level of the mobile phone. #P < 0.01 compared to the control group at the same time point.
Figure 4Plasma levels of (A) tumor necrosis factor (TNF)-α and (B) interleukin (IL)-6 were measured at baseline, 1, 2, 3, 6 months in both groups. The sample size was 12 in the mobile phone group and 14 in the control group at each time point. *P < 0.05, **P < 0.01 ***p < 0.001 compared to the baseline levels of the control group.